Type I pityriasis rubra pilaris treated with tumor necrosis factor inhibitors, ustekinumab, or secukinumab: a systematic review

Publication date: Available online 5 March 2018
Source:Journal of the American Academy of Dermatology
Author(s): Nolan J. Maloney, Lisa D. Hisaw, Scott Worswick




http://ift.tt/2I2phop